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Abstract
Influenza A(H1N1)pdm09 viruses cause sporadically very severe disease including fatal clinical outcomes associated with
pneumonia, viremia and myocarditis. A mutation characterized by the substitution of aspartic acid (wild-type) to glycine at
position 222 within the haemagglutinin gene (HA-D222G) was recorded during the 2009 H1N1 pandemic in Germany and
other countries with significant frequency in fatal and severe cases. Additionally, A(H1N1)pdm09 viruses exhibiting the
polymorphism HA-222D/G/N were detected both in the respiratory tract and in blood. Specimens from mild, fatal and
severe cases were collected to study the heterogeneity of HA-222 in A(H1N1)pdm09 viruses circulating in Germany between
2009 and 2011. In order to enable rapid and large scale analysis we designed a pyrosequencing (PSQ) assay. In 2009/2010,
the 222D wild-type of A(H1N1)pdm09 viruses predominated in fatal and severe outcomes. Moreover, co-circulating virus
mutants exhibiting a D222G or D222E substitution (8/6%) as well as HA-222 quasispecies were identified (10%). Both the
222D/G and the 222D/G/N/V/Y polymorphisms were confirmed by TA cloning. PSQ analyses of viruses associated with mild
outcomes revealed mainly the wild-type 222D and no D222G change in both seasons. However, an increase of variants with
222D/G polymorphism (60%) was characteristic for A(H1N1)pdm09 viruses causing fatal and severe cases in the season
2010/2011. Pure 222G viruses were not observed. Our results support the hypothesis that the D222G change may result
from adaptation of viral receptor specificity to the lower respiratory tract. This could explain why transmission of the 222G
variant is less frequent among humans. Thus, amino acid changes at HA position 222 may be the result of viral intra-host
evolution leading to the generation of variants with an altered viral tropism.
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Introduction
Influenza A(H1N1)pdm09 viruses are characterized by an
unique combination of gene segments. The PB2, PB1, PA, HA,
NP and NS genes are similar to those previously detected in triple-
reassortant swine influenza viruses circulating in pigs in North
America whereas the NA and M segments are most closely related
to genes of influenza A viruses found in swine in Eurasia. The
genes encoding HA, NP and NS of the previous North American
triple-reassortant swine influenza A (H1) virus originated from
classic swine influenza A viruses, PB2 and PA genes from avian
influenza viruses from the North American lineage and the PB1
gene from human influenza A viruses A(H3N2) [1,2]. In the
course of the A(H1N1)pdm09 pandemic the virus caused globally
around 201,200 respiratory deaths and 83,300 cardiovascular
deaths [3]. The A(H1N1)pdm09 virus has shifted into the post
pandemic period since 10th of August 2010 and is still circulating
worldwide. In Germany, 40,548 clinical/laboratory confirmed
influenza cases were reported to the Robert Koch-Institut (RKI)
from the first of October 2010 to the 15th of April 2011. Of these,
6,216 (15%) were hospitalized. Sentinels proved that the majority
of confirmed influenza cases (62%) were A(H1N1)pdm09 viruses.
Moreover, of 148 fatal cases 126 (85%) were attributed to an
A(H1N1)pdm09 infection [4].
In the course of the A(H1N1)pdm09 pandemic a D222G (H1
numbering) substitution in the viral haemagglutinin (HA) gene was
detected with significant frequency in fatal and severe cases [5,6].
The HA protein is an antigenic surface protein and mediates both
the binding of the virus to the host cell and the subsequent fusion
process. The receptor binding site (RBS) of the HA protein is
composed of three structural elements: a 190-helix (residues 184–
191), a 220-loop (residues 218–225), and a 130-loop (residues 131–
135), while other highly conserved residues, (Tyr91, Trp150,
His180, and Tyr192) form the base of the pocket [7]. Parts of the
RBS represent antigenic sites, as shown for the conserved amino
acid (aa) 192 and aa 184–191 in the 190-helix (Sb) and aa 222 in
the 220-loop (Ca2) [8]. The receptor-binding specificity of avian
and human influenza viruses is defined by the aa exposed in the
HA receptor-binding pocket. Human influenza viruses preferably
attach to sialic acid that is linked to galactose by an a2,6-linkage
(SAa2,6Gal) which is found on human epithelial cells in nasal
mucosa, paranasal sinuses, pharynx, trachea and bronchi. In
comparison, avian influenza viruses preferentially bind to
SAa2,3Gal expressed on epithelial cells in the intestinal tract of
waterfowl [9,10].
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A hypothesis suggests that the virus causing the Spanish Flu
A(H1N1) in 1918 was able to cross the species barrier between
birds and humans by mutations in the HA which changed the
binding preference from the avian to the human form [11].
Comparison of the avian HA consensus sequence with HA
sequences from the 1918 influenza virus demonstrates that only
one or two of the conserved residues (187, 222), depending on the
viral isolate, are different [12]. Accordingly, for H1 HAs it could
be shown that aa at positions 187 and 222 define the receptor-
binding specificity. HA-187D and HA-222D lead to the binding of
human-type receptors, whereas 187E and 222G induce binding to
avian-type receptors [9,13]. In contrast to earlier assumptions,
these avian-type receptors are not restricted to birds. They are also
located on human epithelial cells lining the respiratory bronchiole
and the alveolar walls and could, therefore, enable highly
pathogenic viruses like A(H5N1) to replicate in the lower
respiratory tract [9,10].
In the current study, we focused particularly on the residue 222
representing a major determinant of HA receptor specificity in H1
HAs because mutations at position 222 could potentially change
viral tropism and may lead to greater intra-host evolution. We
report on the analysis of the residue 222 within the HA gene of
A(H1N1)pdm09 viruses using the PSQ technique and show that
the prevalence of HA-222 quasispecies increased from 2009/2010
to 2010/2011, from 10.2% to 60%.
Materials and Methods
Ethics Statement
The clinical samples were taken from patients exhibiting
influenza-like illness (ILI) who gave verbal consent for laboratory
examination. The verbal consent was not documented. Samples
were sent to the National Reference Centre (NRC) for Influenza at
the RKI (Berlin, Germany) for influenza virus surveillance
purposes in Germany. Specimens from patients with mild
respiratory infections were taken by sentinel practitioners, samples
from severe and fatal respiratory cases were collected by the
attending physicians in hospitals. The medical practices were
located all over Germany. The analyses of all data were done
anonymously. Consequently, ethic committee approval was not
required since such a sentinel surveillance is covered by German
legislation (113, 114, Protection against Infection Act).
Clinical samples
Human nasopharyngeal aspirates, nasal or throat swabs (upper
airway) as well as tracheal or bronchial secretions, bronchoalveolar
lavages (BAL), lung (lower airway) or heart tissues and RNA or
cDNA were analyzed that were collected in the seasons 2009/
2010 and 2010/2011 (from October until April). The clinical
outcome (mild, severe or fatal) was classified according to World
Health Organization (WHO) guidance criteria [14]. Mild
influenza is associated with typical ILI symptoms, including
sudden onset, fever, cough, sore throat, rhinorrhoea, headache,
muscle pain and malaise, but no shortness of breath and no
dyspnoea. Patients may present with some or all of these
symptoms. Severe influenza is associated with clinical (e.g.
shortness of breath/dyspnoea, tachypnea and/or hypoxia) and/
or radiological signs of lower respiratory tract disease (e.g.
pneumonia) or other complications (e.g. myocarditis). For more
detailed information please refer to WHO guidance criteria [14]
and Table 1. Specimens from mild cases were collected from the
upper airway, and specimens from fatal and severe cases were
collected from both the upper and the lower airways. Swabs were
transported in 1 ml UTM-RT medium (Copan, Murrieta, USA)
and upon arrival adjusted to 3 ml with sterile minimal essential
medium with HEPES (Gibco BRL, Eggenstein, Germany) and
100 U/ml penicillin-streptomycin (Gibco) and aliquoted. For cell
culturing, an aliquot of each specimen was filtered (0.2 mm).
Specimens were stored at 270uC. Other specimens, like
nasopharyngeal aspirates, tracheal or bronchial secretions as well
as BAL were used undiluted. Viscous samples were liquefied by N-
acetyl-cysteine.
Viruses and bacteria
Influenza A(H1N1)pdm09 viruses were obtained from the strain
collection of the NRC Influenza at RKI and were collected during
2009/2010 and 2010/2011. Enteroviruses were provided by S.
Diedrich (NRC for Poliomyelitis and Enteroviruses at RKI).
Respiratory bacteria like Streptococcus pneumoniae were provided by
M. van der Linden (NRC for Streptococci at the Institute for
Medical Microbiology, University Hospital, Aachen, Germany)
and Staphylococcus strains by W. Witte (NRC for Staphylococci
at RKI).
RNA extraction and cDNA synthesis
Viral RNA were extracted using 400 ml diluted specimen and
the MagAttract Viral RNA Kit M48 (Qiagen, Hilden, Germany)
or the RTP DNA/RNA Virus Mini Kit (Invitek, Berlin,
Germany). Tissue samples from heart and lung were thoroughly
crushed prior RNA extraction. cDNA synthesis was performed
using 25 ml RNA and 15 ml reaction mixture containing dithio-
threitol (DTT, 2.5 mM, Invitrogen, Karlsruhe, Germany), deox-
ynucleotide triphosphates (dNTPs, each of 200 mM, Invitrogen),
random hexamer primers (500 nM, Metabion, Martinsried,
Germany), 1 U RNasin (Promega, Madison, WI) and 5 U
moloney murine leukemia virus (M-MLV) reverse transcriptase
in first-strand buffer (Invitrogen). RT reaction was performed
under the following conditions: 42uC (5 min), 37uC (30 min) and
95uC (5 min). Extraction control and identification of
A(H1N1)pdm09 virus-positive samples were done by real-time
PCR of HA, NA and M segments [15].
A(H1N1)pdm09 virus-specific RT-PCR
A(H1N1)pdm09 virus-specific RT-PCRs were performed with a
PE 9700 thermal cycler (Perkin Elmer, Massachusetts, USA) or
Eppendorf thermal cycler (Eppendorf AG, Hamburg, Germany)
using primer listed in Table 2. Each PCR was performed using
5 ml cDNA per 50 ml reaction volume containing MgCl2 (2 mM,
Invitrogen), dNTPs (each of 200 mM, Invitrogen), primer
forward/reverse (250 nM, Tib Molbiol, Berlin, Germany) and
1 U PlatinumTaq in PCR buffer (Invitrogen) under the following
conditions: HAsw-F554/R768: 94uC (5 min), 45 cycles 94uC
(15 sec), 54uC (30 sec), 72uC (30 sec) and finally 72uC (5 min). To
confirm amplification, PCR products were analyzed on a 2%
agarose gel and visualized by ethidium bromide staining under
UV illumination. The amount of PCR products was quantified
with the appropriate software (Herolab, Wiesloch, Germany).
PSQ
About 30 ml of biotinylated PCR fragment (,300 bp) were
immobilized onto 4 ml Streptavidin-Sepharose (Healthcare Bio-
Sciences AB, Uppsala, Sweden) including binding buffer (Biotage/
Qiagen) by incubation at room temperature for 5 min, followed by
additional 5 min at room temperature with agitation at
1,400 rpm. Single-stranded DNA was obtained by washing the
immobilized PCR product with 70% EtOH, denatured with
0.2 M NaOH, and washed with washing buffer (Biotage/Qiagen),
A(H1N1)pdm09 HA-222D/G Polymorphism
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e57059
using a Vacuum Prep Tool and Vacuum Prep Worktable
(Biotage/Qiagen). The immobilized single-stranded DNA was
then suspended in 40 ml annealing buffer (Biotage/Qiagen)
containing 40 pmol sequencing primer and hybridized to the
sequencing primer by incubation at 80uC for 2 min and at room
temperature for 5 min. Primed DNA was sequenced using the
PyroMark ID system (Biotage/Qiagen). Sequencing was per-
formed in a total volume of 40 ml using 5696 PyroMark ID Pyro
Gold Reagent (Biotage) and specific cyclic sequence analysis
(SQA) entry for each PSQ of de novo sequence strategy. Negative-
control nucleotide samples were included to measure background
signals (controls recommended by Biotage/Qiagen). Raw data
were analyzed with BioEdit using reference sequences for
alignment. Sequencing primer and target sequences are listed in
Table 2.
A(H1N1)pdm09 virus HA-specific quantitative real-time
PCR
The amount of HA genome copies in A(H1N1)pdm09 virus
specimens was analyzed by pandemic H1-specific real-time PCR
using the Light Cycler 480 (Roche, Basel, Switzerland). A standard
curve was created by three times of serial dilution (106–100 copies/
PCR) of synthetic H1 plasmid. Real-time PCR was performed
using 3–5 ml cDNA or plasmid and a reaction mixture including
MgCl2 (5 mM, Invitrogen), dNTPs (each of 200 mM, Invitrogen)
containing dUTPs (GE Healthcare), primer FluSw H1 F236
(300 nM), primer FluSw H1 R318 (300 nM), FluSw H1 probe
TM292 (100 nM) and 0.5 U PlatinumH Taq DNA Polymerase in
PCR buffer (Invitrogen). Finally, the PCR mixture was adjusted to
a total volume of 25 ml with H2O and the real-time PCR was
carried out under the following conditions: 95uC (5 min), 45 cycles
of 95uC (15 sec), 60uC (30 sec) [15].
Cycle sequencing
PCR products of amplified HA were sequenced by automated
nucleotide cycle sequencing (primer sequence on request). PCR
products were first purified using an MSBH Spin PCRapace Kit
(Invitek) and then sequenced using the BigDyeH Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Darmstadt, Germany)
and a capillary sequencer 3130xl (Applied Biosystems).
TA Cloning
PCR products of amplified HA genes were cloned using the
TOPO TA CloningH Kit (Invitrogen). Freshly produced ampli-
cons (with single 39-deoxyadenosine [A] overhangs) were ligated
into the pCRH2.1-TOPOH vector (insert:vector = 3:1) according to
the protocol for chemically competent E. coli. Following the
cloning reaction, Top10-competent cells were transformed using
the One ShotH chemical transformation protocol. The clones were
selected on ampicillin-containing culture plates and were subse-
quently selected by blue/white screening.
Development of the HA-222 PSQ-PCR assay
PCR and PSQ primers were designed to analyze the aa 222 on
the HA gene of A(H1N1)pdm09 viruses. Viral RNA sequences
were acquired from the Global initiative on sharing all influenza
data (GISAID), Genbank at the National Centre for Biotechnol-
ogy Information (NCBI) and NRC for Influenza at the RKI,
Germany, and aligned with Bio Edit (7.0.9.0) and MEGA 4.0.2.
Specific RT-PCR and PSQ primers were designed with PyroMark
Assay Design Software 2.0 (Biotage AB, Uppsala, Sweden). The
designed primers (Table 2) were evaluated for A(H1N1)pdm09
virus specificity by BLAST (NCBI) and PCR methods. Blast
search revealed that the PCR-PSQ primer were highly specific for
A(H1N1)pdm09 viruses which was confirmed by PCR. Influenza
A and B, other respiratory viruses and bacteria were prepared for
determination of cross-reactivity of designed A(H1N1)pdm09 virus
HA-222 PCR. No cross-reactivity of designed primers either with
other influenza A subtypes and type B viruses or other respiratory
viruses and bacteria was observed. The sensitivity of the designed
HA-222-PCR was determined using 15 A(H1N1)pdm09 PCR-
positive, randomly selected specimens containing different viral
loads (CT 20–37). A positive result was obtained for all specimens
that had real-time PCR CT values of 35 or lower. Thus, the
detection limit of the designed PCR assay was about ten genome
copies. The sensitivity of the HA-222 PSQ-PCR assay was
determined using A(H1N1)pdm09 variants circulating in 2009/
2010 and 2010/2011 and was evaluated on at least two separate
occasions. The concentration of the genome copies in the viral
cDNAs was determined by pandemic H1-specific real-time PCR.
The viral cDNAs were serially diluted to final concentrations from
106 to 100 genome copies per assay and the HA-222 target was




positive (n = 55) in 2009/2010
Patients A(H1N1)pdm09 PCR-
positive (n = 52) in 2010/2011
Age in median years (range) 39 (0–73) 38 (0–66)
Male 25 28
Female 21 20
Underlying illness (e.g. example asthma, diabetes): 16 11
Including immunosuppressed patients and patients with leukemia 6 7
Pneumonia, acute respiratory distress syndrome (ARDS), respiratory insufficiency 9 24(*including 9 sentinel samples)
Intensive care unit (ICU), ventilation 7 5
Myocarditis/encephalitis symptom 3 2
Fatal cases 26 15
The characteristics were indicated as provided by the attending physicians.
*In 2009/2010 and 2010/2011 the A(H1N1)pdm09 PCR-positive samples associated with fatal and severe outcomes which were provided by hospitals were analyzed in
the current study. Additionally, in 2010/2011 all sentinel samples sent by the medical practices were screened and the A(H1N1)pdm09 PCR-positive specimens that were
associated with pneumonia were included in the group of severe outcomes.
doi:10.1371/journal.pone.0057059.t001
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amplified and pyrosequenced. The PSQ analysis revealed that
about ten genome copies were provable. To determine the
sensitivity of the assay for detection of HA-222D/G polymor-
phism, 222D and 222G variants were amplified by the designed
HA-PCR and TA cloned. Subsequently, the clones were serially
diluted to final concentration from 106 to 101 genome copies per
PCR assay, adjusted to defined 222D/G mixtures (100/0, 95/5,
90/10, 80/20, 50/50, 20/80, 10/90, 5/95, 0/100%) and were
amplified and pyrosequenced. The sensitivity of the PSQ-PCR
was evaluated on at least two separate occasions and was carried
out twice. The evaluation of the pyrograms revealed that the assay
for identification of HA-222 variants in mixtures was linearly from
106 (maximum tested) to 103 genome copies (approximately CT
18–29). In this range the detection limit of minor variants was
about 10%.
Results
PSQ analysis of the aa 222 on HA gene
To analyse the residue 222 within the HA gene of
A(H1N1)pdm09 viruses specimens from mild (n = 159/99) and
fatal and severe (n = 49/50) cases were collected in the 2009/2010
and 2010/2011 seasons, respectively. For rapid and large scale
analysis of the polymorphic marker HA-222 a PSQ-PCR assay
was designed (Table 2). A cyclic dispensation order (ACGT)10 was
used for HA-222 analysis in cases from the season 2009/2010
resulting in the detection of HA-222 variants, as shown for HA-
222D (Fig. 1A). The identified HA-222 quasispecies have to be
confirmed by TA cloning and subsequent PSQ. To avoid the time
consuming cloning procedure, the PSQ assay has been further
developed to allow for a more detailed analysis. In a first step, the
standard cyclic dispensation order (ACGT)10 was applied which is
suitable and sensitive for detection of pure variants and mixtures of
those variants (Figure 1B). In a second step, the customized
dispensation order ATATGTAT(ACGT)5 was used (Figure 1C).
This customized entry enabled successively the identification of the
aa (codons) 222N (AAT), 222Y (TAT), 222G (GGT), 222V
(GTT), 222E (GAA) and 222D (GAT).
PSQ analysis revealed for 2009/2010 that out of 159 mild cases,
13 (8.2%) showed a D222E substitution, one (0.6%) a D222N
change and 145 (91.2%) represented the wild-type 222D. Out of
49 severe including 24 fatal cases, three (6.1%) possessed 222E and
four (8.2%) exhibited 222G. Furthermore, five (10.2%) heteroge-
neous HA-222 specimens were identified, suggesting that the
tested samples contained different virus variants. These heteroge-
neous populations were found in one severe and four fatal cases,
but not in mild infections (Table 3). TA cloning and PSQ as well as
cycle sequencing analysis of extracted viral nucleic acids confirmed
the presence of a 222D/G heterogeneity in a severe case (Fig. 2)
and a 222D/G/N/V/Y polymorphism in a fatal case (Fig. 3).
Similar to the previous influenza season, comparable results
were obtained for A(H1N1)pdm09 viruses derived from mild cases
during 2010/2011 since the majority (98%) represented the wild-
type 222D. One out of 99 mild cases showed a D222E and one a
D222N substitution (each 1%). However, the patterns for HA-222
markers in fatal and severe cases changed strikingly in 2010/2011.
The majority of A(H1N1)pdm09 viruses derived from those cases
showed a heterogeneous expression of HA-222 since 30 (60%) had
a 222D/G polymorphism, two (4%) expressed 222D/G/N and 18
(36%) corresponded to the wild-type 222D (Table 3). Moreover,
the 222D/G polymorphism was detected more frequently in fatal
(73%) and hospitalized (59%) cases than in community patients
exhibiting pneumonia (33%, data not shown). Pure 222G variants
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We were also interested to elucidate whether the age
distribution of patients infected with the distinct HA-222 variants
varied in both seasons. The analysis of 48 specimens from fatal and
severe cases collected in 2010/2011 revealed that the median age
of patients infected with the 222D wild-type was 38 and the
median age of patients infected with the 222D/G quasispecies was
39 years, respectively. In contrast, PSQ data of 39 specimens from
fatal and severe cases collected in 2009/2010 showed that the
wild-type was more frequently identified in younger patients
(median age 22 years) whereas the 222G variant and 222
polymorphisms were more prevalent in older patients (median
age 52 years). In both seasons, the median age of patients with
mild outcomes was 12 and 10 years, respectively (Table 4).
Figure 1. Detection of pure and heterogeneous HA-222 variants using the cyclic dispensation order (ACGT)10 and the customized
dispensation order ATATGTAT(ACGT)5. The pyrograms represent the wild-type HA-222D (GGAT) using the PSQ primer SF662 and (ACGT)10 (A),
HA-222D/G (GGAT/GGGT) polymorphism of a fatal case (448/11) utilizing the PSQ primer SF662A and (ACGT)10 (B) and HA-222D/G/N polymorphism
of the same specimen (448/11) as in (B) applying the PSQ primer SF663 and ATATGTAT(ACGT)5 (C).
doi:10.1371/journal.pone.0057059.g001
Figure 2. PSQ analysis of a HA-222D/G polymorphism detected in a severe case. The pyrogram shows a HA-222 polymorphism (specimen
3004/10) (A). After amplification and TA cloning of the HA-222 fragment, 30 clons were picked and subsequently pyrosequenced using the cyclic
entry (CTGA)10. Fifteen clones are identified as wild-type 222D with codon GGAT (B) and 15 clones as variant 222G with codon GGGT (C).
doi:10.1371/journal.pone.0057059.g002
A(H1N1)pdm09 HA-222D/G Polymorphism
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Emergence, prevalence and tissue distribution of the HA-
222 quasispecies
To investigate the emergence of the HA-222 quasispecies in the
course of an A(H1N1)pdm09 virus infection, five specimens
obtained from a patient with a severe course of disease were
analyzed. The 48-year-old man was hospitalized, immune
suppressed and received extracorporeal membrane oxygenation
(ECMO) as well as Zanamivir and Oseltamivir therapy. The
antiviral treatment started 11 days after onset of ILI symptoms.
Specimens were collected from the lower respiratory tract (BAL)
within 50 days after the onset of ILI symptoms. Real-time PCR
analysis showed that the total amount of genome copies decreased
between days 16 and 50 after the onset of ILI symptoms by an
about one thousand-fold (d16 (CT 28), d22 (CT 28), d29 (CT 32),
d36 (CT 34), d43 (CT 38) and d50 (PCR negative). The PSQ
analysis revealed that the wild-type 222D was predominant in the
initial phase of the disease but declined with its progression.
Twenty-nine days after the onset of ILI symptoms the 222G
variant appeared and the 222D/G quasispecies was detectable
until day 43. During this time period the proportion of the 222G
variant increased relative to the wild type 222D (Fig. 4).
Eighteen fatal and severe cases from 2010/2011 were further
analyzed to elucidate putative correlations between the HA-222
polymorphism and the duration of the disease. Generally, each
specimen represented one single time point. This analysis lead to
the detection of 222D/G polymorphisms in later phases of
infection and the median time after onset of ILI symptoms was
four days. In contrast, the 222D wild-type was identified in an
earlier phase of infection. The median time after onset of ILI
symptoms was one day which is comparable with the group of
mild cases infected with the 222D wild-type. Five of the nine
severe cases that were infected with the 222D virus represented
community patients associated with pneumonia (median time one
day). The remaining four patients were hospitalized (median time
Figure 3. PSQ analysis of a HA-222D/G/N/V/Y polymorphism identified in a fatal case. The pyrogram represents a HA-222 polymorphism
(specimen 3070/10) (A). After amplification and TA cloning of the HA-222 fragment, 23 clones were analyzed using the cyclic entry (CTGA)10. Three of
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three days). In contrast, in the panel of samples collected in 2009/
2010, the 222D wild-type was identified in later phases of disease
(median time five days) mainly in hospitalized patients with a
severe outcome. In this context, no data were available for the
group of severe cases associated with the D222G change in 2009/
2010 (Table 5).
To determine the prevalence of the D222G substitution and the
222D/G quasispecies in different compartments of the respiratory
tract, upper and lower airway samples received from fatal and
severe cases in 2009/2010 and 2010/2011 were analyzed. In
general, each specimen represented one patient, because paired
upper and lower airway specimens were rarely received. PSQ
analysis showed that in the seasons 2009/2010 and 2010/2011 the
222G variant or 222 quasispecies were detectable in upper
respiratory tract samples (15.4% and 57.9%, respectively) as well
as with slightly higher prevalence in the lower respiratory tract
(18.8% and 64.7%, respectively; Table 6). Interestingly, the
analysis of the 222D/G mixtures identified in 2010/2011 revealed
that the proportion of 222G was generally higher in the lower than
in the upper airway (data not shown).
To study further the tissue distribution of the HA-222
quasispecies within a patient at one time-point, three specimens
collected in 2010/2011 from a patient with a fatal outcome were
analyzed. The 10-year-old boy had received intensive care and
mechanical ventilation prior to its death. Specimens were taken
from the upper airway (nasal swab), from the lower airway (lung
tissue) and from the heart tissue. PSQ analysis showed that the
wild-type 222D predominated in the nasal swab. However, the
proportion of the 222G variant was increased slightly in the lung
and profoundly in the heart tissue (Fig. 5). Notably, the total
amount of HA genome copies, in the nasal swab sample (CT 29)
was between hundred and thousand times higher than in the lung
(CT 36) or in the heart tissue (CT 39), respectively, as quantified
by real-time PCR.
Discussion
In this study we analyzed the HA-222 polymorphism in
influenza A(H1N1)pdm09 viruses associated with fatal and severe
clinical outcomes in Germany since October 2009. Studies from
Norway, Hong Kong and Scotland had shown that the D222G
change was detectable in viruses obtained from fatal and severe
cases and ranged in this group between 4 and 18% [5,6,16,17].
Moreover, the European Centre for Disease Prevention and
Control [18] and the World Health Organisation [19] reported on
the appearance of 222G variants in 20 other countries, occasion-
ally also in mild cases. Accordingly, the D222G mutation was
Table 3. Detection of co-circulating HA-222 variants of influenza A(H1N1)pdm09 viruses identified during 2009/2010 and 2010/
2011 by PSQ analysis.
2009/2010 2010/2011
HA-222A Mild cases Fatal cases
Fatal and







% n % n P % n P % n % n P % n P
D 91.2 145 70.8 17 0.009 75.5 37 0.006 98 97 13.3 2 ,0.001 36 18 ,0.001
E 8.2 13 8.3 2 1 6.1 3 0.768 1 1 0 0 1 0 0 1
G 0 0 4.2 1 0.131 8.2 4 0.003 0 0 0 0 NA 0 0 NA
N 0.6 1 0 0 1 0 0 1 1 1 0 0 1 0 0 1
D/G 0 0 73.3 11 ,0.001 60 30 ,0.001
D/G/N 0 0 13.3 2 0.016 4 2 0.111
PMB 0 0 16.7 4 ,0.001 10.2 5 ,0.001
Total 100 159 100 24 100 49 100 99 100 15 100 50
NA: not applicable.
P: p-value of difference of fatal/fatal and severe versus mild cases with HA-222 mutation, calculated by Fisher’s exact test, two-sided.
AFor identification of HA-222 variants, RNA was extracted from patient specimens. Mild cases collected in 2009/2010 constituted an exception, because only 10% were
represented by patient specimens and 90% by cell culture isolates, respectively.
BPM: polymorphism. In 2009/2010, HA-222 polymorphisms were detected using the PSQ primer SF662 and the cyclic entry (ACGT)10. All HA-222 variants in mixtures
could not be clearly identified by the applied cyclic entry. Two quasispecies (222D/G, 222D/G/N/V/Y) could be confirmed by TA cloning and subsequent
pyrosequencing. In 2010/2011, direct pyrosequencing of all circulating 222 variants and quasispecies could be realized by the application of the PSQ primer SF663 and
the customized entry ATATGTAT(ACGT)5.
doi:10.1371/journal.pone.0057059.t003
Table 4. Age distribution of patients infected with different
HA-222 variants or HA-222 quasispecies.
Age of mild cases
Age of fatal and severe
cases
2009/2010 Median Range N Median Range N
D 12 1–84 122 22 0–75 32
G, D/G, PM 52 0–65 6
D/G/N/V/Y 71 - 1
Total 122 39
2010/2011
D 10 0–57 94 38 1–67 15
D/G 39 0–66 31
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identified in some mild cases (0.9%) but predominated in fatal and
severe cases (5.8%) in Italy [20].
Evidence has been provided that a H1N1 virus variant (A/New
York/1/18) circulating during the Spanish Flu 1918 also
expressed HA-222G [11] which binds to both human SAa2,6Gal-
and avian SAa2,3Gal-receptors [21]. Recently, similar receptor
specificity was shown for 222G variants of A(H1N1)pdm09 virus
[22,23]. These findings required further studies since SAa2,3Gal-
Figure 4. Emergence of the HA-222D/G quasispecies during a severe course of disease. The BAL samples were collected 22, 29 and 43
days after the onset of ILI symptoms (specimens 3340/11, 3341/11, 3343/11). The pyrograms show the wild-type 222D (GAT) (A), the emergence of
the 222G variant (B) and the increase of the 222G variant (C) relative to the wild-type 222D.
doi:10.1371/journal.pone.0057059.g004
Table 5. Time after onset of ILI symptoms and occurrence of the HA-222G variant or HA-222 quasispecies.
Days after onset of ILI-symptoms
Mild cases Fatal and severe cases
Community patients ACommunity patients Hospitalized patients
ACommunity and
hospitalized patients
2009/2010 Median Range N Median Range N Median Range N Median Range N





D 1 0–5 91 1 0–4 5 3 0–7 4 1 0–7 9
D/G 4 - 2 4 2–5 7 4 2–5 9
D/G/N
Total 91 18
The specimens of the 48-year-old hospitalized man that were collected within 50 days after onset of ILI symptoms were not included in the analysis. Generally, each
specimen represented one single time point.
AThe community patients associated with pneumonia were included in the group of fatal and severe cases.
doi:10.1371/journal.pone.0057059.t005
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receptors were identified in the lower respiratory tract of humans
and thus 222G variants might course a more severe disease [10].
Studies in a ferret model showed that the HA wild-type of the
recombinant 1918 virus with the 187D/222D constellation
conferred efficient transmission between animals, but that the
HA-187D/222G mutant was inefficiently transmitted [24].
Interestingly, decreased transmission was not observed for the
222G variant of the A(H1N1)pdm09 virus, since the introduced
D222G substitution had no detectable effect on transmission in
animal models tested [23].
During the pandemic in 2009/2010, the D222G substitution
described here was associated with fatal and severe clinical
outcomes. Moreover, the wild-type 222D and the variant 222G
could be identified in a specimen obtained from a severe case. This
Table 6. Prevalence of co-circulating HA-222 variants and HA-222 quasispecies of influenza A(H1N1)pdm09 viruses in the upper
and lower respiratory tract identified in 2009/2010 and 2010/2011.
Mild cases - upper respiratory tract
Fatal and severe cases - upper
respiratory tract
Fatal and severe cases -
lower respiratory tract
2009/2010 % n % n % n
D 100.0 122 84.6 11 75.0 12
G, D/G, PM 15.4 2 18.8 3
D/G/N/V/Y 6.3 1
Total 100.0 122 100.0 13 100.0 16
2010/2011
D 100.0 94 42.1 8 29.4 5
D/G 57.9 11 64.7 11
D/G/N 5.9 1
Total 100.0 94 100.0 19 100.0 17
Data represented mainly single upper or lower airway specimens of one patient.
doi:10.1371/journal.pone.0057059.t006
Figure 5. Tissue distribution of the HA-222D/G quasispecies associated with a fatal clinical outcome. A nasal swab, lung and heart tissue
samples were collected (specimens 2158–2160/11). The pyrograms demonstrate a 222D/G (GAT/GGT) polymorphism in the nasal swab (A), an
increase of 222G in the lung (B) and in the heart tissue (C) relative to the wild type 222D.
doi:10.1371/journal.pone.0057059.g005
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observation was in accordance with other studies reporting on
222G and 222N viruses and sometimes mixtures thereof [5,6,16–
18,25]. Furthermore, A(H1N1)pdm09 viruses identified between
May and July 2009 in Australia showed also a 222D/G/N/S
polymorphism. This heterogeneity was observed in virus speci-
mens from severe cases but was also found in those from mild cases
[26]. Here we describe for the first time the identification of a
222D/G/N/V/Y polymorphism in the lower airway of a fatal
case. Analysis of HA sequences submitted to Genbank from April
2009 to May 2010 revealed no similar HA heterogeneity. The
emergence of such diverse polymorphism of HA-222 (222D/G/
N/V/Y) might be explained by adaptation of viral receptor
specificity to the lower respiratory tract in the course of viral
evolution in humans. Accordingly, as reported here and in a study
from China [25] the HA-222 polymorphism was more frequently
detected in the lower airway of A(H1N1)pdm09 infected patients.
As shown in this study, high variability of HA-222 (one case of
222D/G/N/V/Y and two cases of 222D/G/N polymorphism)
were exclusively identified in fatal cases. Further studies will be
required to determine the relevance of this heterogeneity in
position 222 of the HA for viral receptor specificity and
pathogenicity.
In the post-pandemic period during 2010/2011, an increase of
heterogeneous HA-222 viruses from fatal and severe cases was
observed in Germany since 60% exhibited a 222D/G polymor-
phism. However, almost all viruses from mild cases displayed the
wild-type HA-222D. Controversial results were reported from
England [27] demonstrating that viruses from fatal and non-fatal
outcomes, circulating in 2010/2011, generally had 222D in the
HA gene. In contrast, a study from Italy showed that 222G/N
variants were more frequently detected in patients admitted to the
intensive-care unit for invasive mechanical ventilation or extra-
corporeal membrane oxygenation than in patients hospitalized in
other units and community patients [28,29]. Accordingly, the
222D/G polymorphism described here was more abundant in the
fatal and in the hospitalized cases than in the community patients.
Regarding sampling time and the course of disease it should be
noted that the specimens of community patients were mostly
collected earlier after the onset of ILI symptoms than those of
hospitalized patients, which are usually analyzed later after their
admission to the clinics. In severe and fatal cases from 2010/2011,
the HA-222 polymorphism was more abundant in later phases of
infection and was rarely present in earlier phases suggesting that
the D222G substitution occurred upon intra-host evolution.
Interestingly, no D222G change was detected in specimens from
hospitalized younger patients (median age 22 years) during 2009/
2010, although the patients were infected for several days with the
222D variant. However, the HA-222 polymorphism predominat-
ed in older patients (median age 52 and 39) in both seasons. Thus,
the marked difference concerning the prevalence of the 222D/G
polymorphism between the two seasons analyzed might be
attributed to the fact that in 2009/2010 frequently children that
were not susceptible for viral residue 222 evolution experienced a
severe outcome. In 2010/2011, predominantly adults developing a
severe outcome were susceptible for the polymorphism at HA
position 222.
Our data suggest that viruses with a D222G substitution exhibit
an altered tropism which accompanies viral progression into the
lower airways. However, at present it remains unclear whether the
appearance of these variant viruses is a cause or rather a
consequence of more severe disease. It should be noted that the
impact of viral tropism for the pathogenicity of influenza A viruses
is controversially discussed. A study using a human lung model
indicated that differences in the pathogenic potential of
A(H1N1)pdm09 and highly pathogenic avian A(H5N1) viruses
cannot be attributed to a distinct cellular tropism alone, but is
rather associated with the capacity to replicate in the type II
pneumocytes and to overcome the induced cytokine response [30].
In contrast, binding studies with A(H1N1)pdm09 viruses showed
that the D222G mutant with dual receptor specificity exhibited
increased binding capacity to ciliated epithelial cells, which are
prominent along the entire airway epithelium, as well as to type II
pneumocytes and alveolar macrophages, respectively. Thus, the
222G variant may have the potential to interfere with the
mucociliary clearance function and to cause more severe
pulmonary infections [22,23].
Here, we demonstrated in a severe A(H1N1)pdm09 infection
that the prevalence of the predominant 222D wild-type decreased,
while there was a relative increase in the proportion of the 222G
variant during the course of infection. Moreover, the analysis of a
fatal case identified the 222D/G polymorphism in the upper and
lower respiratory tract as well as in the heart tissue with increasing
prevalence in the latter ones. These observations suggest a
scenario in which the wild-type virus dominates in the initial
phase of infection associated with high viral loads in the upper
respiratory airway. In the advanced phase of a severe infection also
the lower tract becomes involved and the 222G variant may evolve
by adaptation of viral receptor specificity to cells in the lower
airway. The 222D/G polymorphic viruses may differ in their
efficacy to replicate in the type II pneumocytes, as shown in
human respiratory cells in vitro [31]. Here, we show that the
proportion of 222G increased relative to 222D. Infection of the
type II pneumocytes might result in an impaired cell function
including disrupted repair of the epithelium after alveolar damage
[23]. As a consequence, viremia occurs and the 222D/G viruses
may be transported via the bloodstream to other organs in which
the replication levels are low but sufficiently high to cause
inflammation. Accordingly, in the heart tissue of a fatal case
described in the present study the 222D/G quasispecies was
identified and in other severe cases associated with an
A(H1N1)pdm09 virus infection viremia and myocarditis was
observed [32–35].
Interestingly, an analysis of A(H1N1)pdm09 virus infected
patients revealed that the proportion of the 222G/N quasispecies
in the blood was greater than the corresponding proportion in the
tested respiratory nasopharyngeal and endotracheal aspirates[33].
These findings support the hypothesis that the 222G/N quasis-
pecies developed by adaptation in the lung. Alternatively, the
predominance of the 222G/N variants in the blood might be
explained by differential receptor specificity of the 222D/G/N
viruses to human erythrocytes. In this context it should be noted
that the response of the erythrocytes to viral infections is poorly
understood [36].Complement-dependent binding of immune
complexes to primate erythrocytes via complement receptor 1
was already shown [37]. This immunological defence reaction can
lead to neutralization and clearance of antigens from the blood
[38]. Attachment of influenza viruses via sialic acid receptor
binding to human erythrocytes might provide a comparable,
alternative pathway.
In conclusion, analysis of the HA gene revealed that the
evolution of the A(H1N1)pdm09 viruses is associated with an
increased co-circulation of variants possessing mixed human/
avian receptor specificity due to HA-D222G substitution. Our
data demonstrate that pure 222G variants and 222D/G as well as
222D/G/N and 222D/G/N/V/Y quasispecies co-circulated
mainly in hospitalized patients with fatal and severe outcomes.
Amino acid changes at HA position 222 may be the result of viral
intra-host evolution leading to the generation of variants with an
A(H1N1)pdm09 HA-222D/G Polymorphism
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altered viral tropism. This supports the hypothesis that the D to G
change alone does not make the virus more virulent, but that
positive selection favors some polymorphic variants when com-
pared with corresponding isogenic ones.
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